Catheter Precision, Inc. announced on August 21, 2025, that the LockeT Compare Study has enrolled its first three patients. This study is a single-center, physician-initiated study designed to enroll up to 100 patients.
The LockeT Compare Study will evaluate the safety profile of the LockeT suture retention device in comparison to internal closure devices. This research aims to provide clinical data on LockeT's performance.
David Jenkins, CEO, stated that effective groin management after cardiac catheter procedures is as important as the procedure outcomes. The company believes this study will demonstrate a reduction in thrombotic episodes with LockeT compared to internal closure mechanisms, thereby improving patient safety.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.